Biomarker could help diagnosis schizophrenia at an early age

Research could lead to blood-based diagnostic test for schizophrenia.

Study finds promising therapeutic target for colitis

Study represents a scientific advance toward a targeted therapy for colitis—a chronic digestive disease caused by inflammation of the colon.

Carl F. Ware receives ICIS Honorary Lifetime Membership Award

ICIS honors Carl F. Ware for his seminal and original contributions to our understanding of the role of cytokines in immunology.

Cerecor licenses Sanford Burnham Prebys’ Immune Checkpoint Program

Cerecor expands pipeline of novel biologics that address immunologic and immune-oncologic targets.

Researchers dig deeper into how cells transport their waste for recycling

Findings may have important implications for understanding age-related diseases.